A detailed history of Sg Americas Securities, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 14,270 shares of SAGE stock, worth $77,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,270
Previous 16,278 12.34%
Holding current value
$77,628
Previous $177,000 41.81%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$7.02 - $13.08 $14,096 - $26,264
-2,008 Reduced 12.34%
14,270 $103,000
Q2 2024

Jul 12, 2024

BUY
$10.58 - $17.9 $172,221 - $291,376
16,278 New
16,278 $177,000
Q3 2023

Oct 13, 2023

BUY
$16.75 - $48.98 $30,937 - $90,466
1,847 Added 11.02%
18,607 $383,000
Q2 2023

Jul 10, 2023

BUY
$40.65 - $59.54 $230,404 - $337,472
5,668 Added 51.1%
16,760 $788,000
Q1 2023

Apr 28, 2023

SELL
$37.27 - $46.57 $442,842 - $553,344
-11,882 Reduced 51.72%
11,092 $465,000
Q4 2022

Feb 02, 2023

BUY
$32.2 - $43.61 $401,920 - $544,340
12,482 Added 118.97%
22,974 $876,000
Q3 2022

Oct 31, 2022

SELL
$32.28 - $43.27 $451,564 - $605,304
-13,989 Reduced 57.14%
10,492 $411,000
Q2 2022

Jul 29, 2022

SELL
$27.52 - $37.99 $2.09 Million - $2.89 Million
-76,028 Reduced 75.64%
24,481 $791,000
Q1 2022

Apr 29, 2022

BUY
$30.71 - $45.71 $2.64 Million - $3.93 Million
86,031 Added 594.22%
100,509 $3.33 Million
Q4 2021

Feb 07, 2022

SELL
$37.06 - $47.11 $1.97 Million - $2.51 Million
-53,272 Reduced 78.63%
14,478 $616,000
Q3 2021

Nov 01, 2021

BUY
$40.26 - $57.37 $1.76 Million - $2.5 Million
43,599 Added 180.53%
67,750 $3 Million
Q2 2021

Aug 12, 2021

BUY
$54.88 - $79.29 $234,941 - $339,440
4,281 Added 21.55%
24,151 $1.37 Million
Q1 2021

May 13, 2021

SELL
$70.65 - $96.76 $116,501 - $159,557
-1,649 Reduced 7.66%
19,870 $1.49 Million
Q4 2020

Feb 04, 2021

BUY
$58.41 - $89.06 $238,780 - $364,077
4,088 Added 23.45%
21,519 $1.86 Million
Q3 2020

Nov 09, 2020

BUY
$41.13 - $62.45 $716,937 - $1.09 Million
17,431 New
17,431 $1.07 Million
Q4 2019

Jan 28, 2020

SELL
$60.18 - $154.77 $224,892 - $578,375
-3,737 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$140.29 - $189.96 $228,111 - $308,874
1,626 Added 77.03%
3,737 $524,000
Q2 2019

Jul 29, 2019

BUY
$157.85 - $183.09 $1,104 - $1,281
7 Added 0.33%
2,111 $387,000
Q1 2019

Apr 29, 2019

SELL
$89.33 - $163.65 $114,431 - $209,635
-1,281 Reduced 37.84%
2,104 $335,000
Q4 2018

Feb 01, 2019

BUY
$81.94 - $139.71 $66,371 - $113,165
810 Added 31.46%
3,385 $324,000
Q3 2018

Nov 06, 2018

BUY
$138.11 - $169.04 $232,024 - $283,987
1,680 Added 187.71%
2,575 $364,000
Q2 2018

Aug 07, 2018

SELL
$140.36 - $175.76 $608,881 - $762,446
-4,338 Reduced 82.9%
895 $140,000
Q1 2018

May 03, 2018

BUY
$152.15 - $192.33 $796,200 - $1.01 Million
5,233 New
5,233 $843,000
Q4 2017

Jan 24, 2018

SELL
$60.72 - $167.34 $413,746 - $1.14 Million
-6,814 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$61.4 - $88.52 $418,379 - $603,175
6,814
6,814 $425,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.